{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:14:45Z","timestamp":1790540085157,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2018-12365358"],"award-info":[{"award-number":["GR-2018-12365358"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 2021"],"award-info":[{"award-number":["RC 2021"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 2021"],"award-info":[{"award-number":["RC 2021"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","award":["Ricerca Corrente 2020"],"award-info":[{"award-number":["Ricerca Corrente 2020"]}],"id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","award":["Ricerca Corrente 2020"],"award-info":[{"award-number":["Ricerca Corrente 2020"]}],"id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009703","name":"Fondazione per la Ricerca Biomedica","doi-asserted-by":"publisher","award":["CP 20\/2018"],"award-info":[{"award-number":["CP 20\/2018"]}],"id":[{"id":"10.13039\/501100009703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009703","name":"Fondazione per la Ricerca Biomedica","doi-asserted-by":"publisher","award":["CP 20\/2018"],"award-info":[{"award-number":["CP 20\/2018"]}],"id":[{"id":"10.13039\/501100009703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP19002"],"award-info":[{"award-number":["GGP19002"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Charcot\u2013Marie\u2013Tooth disease type 2A (CMT2A) is a rare inherited axonal neuropathy caused by mutations in <jats:italic>MFN2<\/jats:italic> gene, which encodes Mitofusin 2, a transmembrane protein of the outer mitochondrial membrane. We performed a cross-sectional analysis on thirteen patients carrying mutations in <jats:italic>MFN2<\/jats:italic>, from ten families, describing their clinical and genetic characteristics. Evaluated patients presented a variable age of onset and a wide phenotypic spectrum, with most patients presenting a severe phenotype. A novel heterozygous missense variant was detected, p.K357E. It is located at a highly conserved position and predicted as pathogenic by in silico tools. At a clinical level, the p.K357E carrier shows a severe sensorimotor axonal neuropathy. In conclusion, our work expands the genetic spectrum of CMT2A, disclosing a novel mutation and its related clinical effect, and provides a detailed description of the clinical features of a cohort of patients with <jats:italic>MFN2<\/jats:italic> mutations. Obtaining a precise genetic diagnosis in affected families is crucial both for family planning and prenatal diagnosis, and in a therapeutic perspective, as we are entering the era of personalized therapy for genetic diseases.\n<\/jats:p>","DOI":"10.1038\/s41598-022-10220-0","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T13:04:41Z","timestamp":1649855081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Clinical and genetic features of a cohort of patients with MFN2-related neuropathy"],"prefix":"10.1038","volume":"12","author":[{"given":"Elena","family":"Abati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Manini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Velardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Del Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Moggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nereo","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Pietro","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"10220_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/WCO.0000000000000735","volume":"32","author":"M Laur\u00e1","year":"2019","unstructured":"Laur\u00e1, M., Pipis, M., Rossor, A. M. & Reilly, M. M. Charcot-marie-Tooth disease and related disorders: An evolving landscape. Curr. Opin. Neurol. 32, 641\u2013650 (2019).","journal-title":"Curr. Opin. Neurol."},{"key":"10220_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12013","author":"GJ Braathen","year":"2012","unstructured":"Braathen, G. J. Genetic epidemiology of charcot-marie-tooth disease. Acta Neurol. Scand. Suppl. https:\/\/doi.org\/10.1111\/ane.12013 (2012).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10220_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/jnnp-2012-302451","volume":"83","author":"SM Murphy","year":"2012","unstructured":"Murphy, S. M. et al. Charcot-Marie-Tooth disease: Frequency of genetic subtypes and guidelines for genetic testing. J. Neurol. Neurosurg. Psychiatry 83, 706\u2013710 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10220_CR4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","volume":"86","author":"V Fridman","year":"2015","unstructured":"Fridman, V. et al. CMT subtypes and disease burden in patients enrolled in the inherited neuropathies consortium natural history study: A cross-sectional analysis. J. Neurol. Neurosurg. Psychiatry 86, 873\u2013878 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10220_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ng1341","volume":"36","author":"S Z\u00fcchner","year":"2004","unstructured":"Z\u00fcchner, S. et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36, 449\u2013451 (2004).","journal-title":"Nat. Genet."},{"key":"10220_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-7-53","author":"K Engelfried","year":"2006","unstructured":"Engelfried, K. et al. Charcot-marie-tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2). BMC Med. Genet. https:\/\/doi.org\/10.1186\/1471-2350-7-53 (2006).","journal-title":"BMC Med. Genet."},{"key":"10220_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/brv.12378","volume":"93","author":"G Chandhok","year":"2018","unstructured":"Chandhok, G., Lazarou, M. & Neumann, B. Structure, function, and regulation of mitofusin-2 in health and disease. Biol. Rev. Camb. Philos. Soc. 93, 933\u2013949 (2018).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10220_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/jns.12155","volume":"21","author":"PJ Tomaselli","year":"2016","unstructured":"Tomaselli, P. J. et al. Semi-dominant mutations in MFN2-related neuropathy and implications for genetic counselling. J. Peripher. Nerv. Syst. 21, 52\u201354 (2016).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10220_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1212\/WNL.0b013e3182242d4d","volume":"77","author":"JM Polke","year":"2011","unstructured":"Polke, J. M. et al. Recessive axonal charcot-marie-tooth disease due to compound heterozygous mitofusin 2 mutations. Neurology 77, 168\u2013173 (2011).","journal-title":"Neurology"},{"key":"10220_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/jns.12145","volume":"20","author":"G Piscosquito","year":"2015","unstructured":"Piscosquito, G. et al. Mutational mechanisms in MFN2-related neuropathy: Compound heterozygosity for recessive and semidominant mutations. J. Peripher. Nerv. Syst. 20, 380\u2013386 (2015).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10220_CR11","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1212\/01.wnl.0000311275.89032.22","volume":"70","author":"GA Nicholson","year":"2008","unstructured":"Nicholson, G. A. et al. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations. Neurology 70, 1678\u20131681 (2008).","journal-title":"Neurology"},{"key":"10220_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.expneurol.2009.05.003","volume":"218","author":"R Cartoni","year":"2009","unstructured":"Cartoni, R. & Martinou, J.-C. Role of mitofusin 2 mutations in the physiopathology of Charcot\u2013Marie\u2013Tooth disease type 2A. Exp. Neurol. 218, 268\u2013273 (2009).","journal-title":"Exp. Neurol."},{"key":"10220_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1083\/jcb.200211046","volume":"160","author":"H Chen","year":"2003","unstructured":"Chen, H. et al. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160, 189\u2013200 (2003).","journal-title":"J. Cell Biol."},{"key":"10220_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1083\/jcb.200611080","volume":"176","author":"SA Detmer","year":"2007","unstructured":"Detmer, S. A. & Chan, D. C. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J. Cell Biol. 176, 405\u2013414 (2007).","journal-title":"J. Cell Biol."},{"key":"10220_CR15","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1212\/WNL.0b013e31821a441e","volume":"76","author":"SME Feely","year":"2011","unstructured":"Feely, S. M. E. et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 76, 1690\u20131696 (2011).","journal-title":"Neurology"},{"key":"10220_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa323","author":"M Pipis","year":"2021","unstructured":"Pipis, M. et al. Natural history of charcot-marie-tooth disease type 2A: A large international multicentre study. Brain https:\/\/doi.org\/10.1093\/brain\/awaa323 (2021).","journal-title":"Brain"},{"key":"10220_CR17","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/brain\/awl174","volume":"129","author":"KW Chung","year":"2006","unstructured":"Chung, K. W. et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129, 2103\u20132118 (2006).","journal-title":"Brain"},{"key":"10220_CR18","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/brain\/awl126","volume":"129","author":"K Verhoeven","year":"2006","unstructured":"Verhoeven, K. et al. MFN2 mutation distribution and genotype\/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 129, 2093\u20132102 (2006).","journal-title":"Brain"},{"key":"10220_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","volume":"8","author":"D Pareyson","year":"2009","unstructured":"Pareyson, D. & Marchesi, C. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet. Neurol. 8, 654\u2013667 (2009).","journal-title":"Lancet. Neurol."},{"key":"10220_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1136\/jnnp.2009.181669","volume":"81","author":"KW Chung","year":"2010","unstructured":"Chung, K. W. et al. Early-onset charcot-marie-tooth patients with mitofusin 2 mutations and brain involvement. J. Neurol. Neurosurg. Psychiatry 81, 1203\u20131206 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10220_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ana.24824","volume":"81","author":"M Lee","year":"2017","unstructured":"Lee, M. et al. Cerebral white matter abnormalities in patients with charcot-marie-tooth disease. Ann. Neurol. 81, 147\u2013151 (2017).","journal-title":"Ann. Neurol."},{"key":"10220_CR22","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/01.wnl.0000327095.32005.a4","volume":"71","author":"R Del Bo","year":"2008","unstructured":"Del Bo, R. et al. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology 71, 1959\u20131966 (2008).","journal-title":"Neurology"},{"key":"10220_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jamaneurol.2014.629","volume":"71","author":"F Bombelli","year":"2014","unstructured":"Bombelli, F. et al. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features. JAMA Neurol. 71, 1036\u20131042 (2014).","journal-title":"JAMA Neurol."},{"key":"10220_CR24","doi-asserted-by":"publisher","first-page":"113281","DOI":"10.1016\/j.expneurol.2020.113281","volume":"328","author":"C Picci","year":"2020","unstructured":"Picci, C. et al. HDAC6 inhibition promotes \u03b1-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice. Exp. Neurol. 328, 113281 (2020).","journal-title":"Exp. Neurol."},{"key":"10220_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.aao1785","volume":"360","author":"AG Rocha","year":"2018","unstructured":"Rocha, A. G. et al. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science 360, 336\u2013341 (2018).","journal-title":"Science"},{"key":"10220_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/brain\/awz064","volume":"142","author":"N Schiza","year":"2019","unstructured":"Schiza, N. et al. Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy. Brain 142, 1227\u20131241 (2019).","journal-title":"Brain"},{"key":"10220_CR27","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1093\/hmg\/ddz199","volume":"28","author":"A Kagiava","year":"2019","unstructured":"Kagiava, A. et al. Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X. Hum. Mol. Genet. 28, 3528\u20133542 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"10220_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1529-8027.2011.00350.x","volume":"16","author":"SM Murphy","year":"2011","unstructured":"Murphy, S. M. et al. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. J. Peripher. Nerv. Syst. 16, 191\u2013198 (2011).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10220_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1212\/01.WNL.0000156517.00615.A3","volume":"64","author":"ME Shy","year":"2005","unstructured":"Shy, M. E. et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64, 1209\u20131214 (2005).","journal-title":"Neurology"},{"key":"10220_CR30","doi-asserted-by":"publisher","first-page":"e884","DOI":"10.1212\/WNL.0000000000009035","volume":"94","author":"V Fridman","year":"2020","unstructured":"Fridman, V. et al. A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores. Neurology 94, e884\u2013e896 (2020).","journal-title":"Neurology"},{"key":"10220_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/jns.12084","volume":"19","author":"R Sadjadi","year":"2014","unstructured":"Sadjadi, R. et al. Psychometrics evaluation of charcot-marie-tooth neuropathy score (CMTNSv2) second version, using Rasch analysis. J. Peripher. Nerv. Syst. 19, 192\u2013196 (2014).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10220_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ana.23572","volume":"71","author":"J Burns","year":"2012","unstructured":"Burns, J. et al. Validation of the charcot-marie-tooth disease pediatric scale as an outcome measure of disability. Ann. Neurol. 71, 642\u2013652 (2012).","journal-title":"Ann. Neurol."},{"key":"10220_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"10220_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00439-004-1199-2","volume":"116","author":"K Kijima","year":"2005","unstructured":"Kijima, K. et al. Mitochondrial GTPase mitofusin 2 mutation in charcot-marie-tooth neuropathy type 2A. Hum. Genet. 116, 23\u201327 (2005).","journal-title":"Hum. Genet."},{"key":"10220_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1523\/JNEUROSCI.4798-06.2007","volume":"27","author":"RH Baloh","year":"2007","unstructured":"Baloh, R. H., Schmidt, R. E., Pestronk, A. & Milbrandt, J. Altered axonal mitochondrial transport in the pathogenesis of charcot-marie-tooth disease from mitofusin 2 mutations. J. Neurosci. 27, 422\u2013430 (2007).","journal-title":"J. Neurosci."},{"key":"10220_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/mus.23985","volume":"49","author":"G Bergamin","year":"2014","unstructured":"Bergamin, G. et al. Novel mutation of the mitofusin 2 gene in a family with Charcot-Marie-Tooth disease type 2. Muscle Nerve 49, 145\u2013146 (2014).","journal-title":"Muscle Nerve"},{"key":"10220_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1212\/WNL.56.1.100","volume":"56","author":"M Muglia","year":"2001","unstructured":"Muglia, M. et al. Clinical and genetic study of a large Charcot-Marie-Tooth type 2A family from southern Italy. Neurology 56, 100\u2013103 (2001).","journal-title":"Neurology"},{"key":"10220_CR38","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1242\/jcs.02449","volume":"118","author":"S Honda","year":"2005","unstructured":"Honda, S., Aihara, T., Hontani, M., Okubo, K. & Hirose, S. Mutational analysis of action of mitochondrial fusion factor mitofusin-2. J. Cell Sci. 118, 3153\u20133161 (2005).","journal-title":"J. Cell Sci."},{"key":"10220_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2015.08.1528","volume":"358","author":"H Lv","year":"2015","unstructured":"Lv, H. et al. A cohort study of Han Chinese MFN2-related charcot-marie-tooth 2A. J. Neurol. Sci. 358, 153\u2013157 (2015).","journal-title":"J. Neurol. Sci."},{"key":"10220_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jns.2011.04.025","volume":"307","author":"M Luigetti","year":"2011","unstructured":"Luigetti, M. et al. Clinical, electrophysiological and pathological findings of a patient with CMT2 due to the p.Ala738Val mitofusin 2 mutation. J. Neurol. Sci. 307, 168\u2013170 (2011).","journal-title":"J. Neurol. Sci."},{"key":"10220_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.nmd.2016.10.001","volume":"27","author":"AM Rossor","year":"2017","unstructured":"Rossor, A. M. et al. Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene. Neuromuscul. Disord. 27, 50\u201356 (2017).","journal-title":"Neuromuscul. Disord."},{"key":"10220_CR42","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1212\/WNL.0000000000004296","volume":"89","author":"FB Panosyan","year":"2017","unstructured":"Panosyan, F. B. et al. Cross-sectional analysis of a large cohort with X-linked charcot-marie-tooth disease (CMTX1). Neurology 89, 927\u2013935 (2017).","journal-title":"Neurology"},{"key":"10220_CR43","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1093\/brain\/awv241","volume":"138","author":"O Sanmaneechai","year":"2015","unstructured":"Sanmaneechai, O. et al. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene. Brain 138, 3180\u20133192 (2015).","journal-title":"Brain"},{"key":"10220_CR44","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/19768354.2013.814587","volume":"17","author":"K Nakhro","year":"2013","unstructured":"Nakhro, K., Park, J. M., Choi, B. O. & Chung, K. W. Missense mutations of mitofusin 2 in axonal charcot-marie-tooth neuropathy: Polymorphic or incomplete penetration?. Animal Cells Syst. 17, 228\u2013236 (2013).","journal-title":"Animal Cells Syst."},{"key":"10220_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/jns.12148","volume":"20","author":"M Tufano","year":"2015","unstructured":"Tufano, M. et al. Early onset charcot-marie-tooth neuropathy type 2A and severe developmental delay: Expanding the clinical phenotype of MFN2-related neuropathy. J. Peripher. Nerv. Syst. 20, 415\u2013418 (2015).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10220_CR46","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/archneurol.2011.225","volume":"68","author":"CJ Klein","year":"2011","unstructured":"Klein, C. J. et al. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch. Neurol. 68, 1295 (2011).","journal-title":"Arch. Neurol."},{"key":"10220_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2020.00782","volume":"11","author":"GW Dorn","year":"2020","unstructured":"Dorn, G. W. Mitofusin 2 dysfunction and disease in mice and men. Front. Physiol. 11, 1\u20139 (2020).","journal-title":"Front. Physiol."},{"key":"10220_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature20156","volume":"540","author":"A Franco","year":"2016","unstructured":"Franco, A. et al. Correcting mitochondrial fusion by manipulating mitofusin conformations. Nature 540, 74\u201379 (2016).","journal-title":"Nature"},{"key":"10220_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/nar\/gkt376","volume":"41","author":"H McWilliam","year":"2013","unstructured":"McWilliam, H. et al. Analysis tool web services from the EMBL-EBI. Nucleic Acids Res. 41, 597\u2013600 (2013).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10220-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:38:14Z","timestamp":1669340294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10220-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10220"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10220-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6181"}}